Skip to main content
TipRanks
Go Ultimate75% OFF

Reviva Pharmaceuticals Holdings (RVPH) Q4 2022 Earnings Report

1,273 Followers

RVPH Q4 2022 EPS Results

Actual EPS
-$7.60
Consensus EPS
-$4.40
Beat/Miss
Missed by -$3.20
One Year Ago EPS
-$3.80

RVPH Q4 2022 Revenue Results

Actual Revenue
$0
Expected Revenue
$0
Beat/Miss
Met expectations
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q4 2022
Date
03/30/2023
Time
Before Open
Conference Call
Thursday, March 30, 2023
RVPH Upcoming Earnings

Reviva Pharmaceuticals Holdings's next earnings date is estimated for April 5, 2027, based on past reporting schedules.

Q4 2022 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q4 2022 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2022 Earnings Call Summary

No earnings call summary is available for this earnings event.

RVPH Earnings History

RVPH earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Apr 05, 20272026 (Q4)-0.19--0.46――
Nov 13, 20262026 (Q3)-0.29-0.17-1.285.83% (+1.03)
Aug 12, 20262026 (Q2)-0.39-0.19-2.492.08% (+2.21)
May 13, 20262026 (Q1)-0.35-0.46-2.682.31% (+2.14)
Mar 30, 20262025 (Q4)-1.080.72-2.8125.71% (+3.52)
Nov 13, 20252025 (Q3)-1.90-1.20-576.00% (+3.80)
Aug 14, 20252025 (Q2)-2.35-2.40-5.253.85% (+2.80)
May 15, 20252025 (Q1)―-0.13-597.40% (+4.87)
Mar 31, 20252024 (Q4)-3.94-2.60-548.00% (+2.40)
Nov 14, 20242024 (Q3)-4.88-5.00-8.843.18% (+3.80)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed